Clarification of Block Admission Application (6374J)
July 01 2011 - 11:03AM
UK Regulatory
TIDMMEDG TIDMMEDU
RNS Number : 6374J
Medgenics Inc
01 July 2011
Medgenics, Inc.
(the "Company")
Clarification of Block Admission Application
1 July 2011
Medgenics, Inc. (NYSE Amex: MDGN and MDGN.W and London Stock
Exchange - AIM: MEDG and MEDU), the company that has developed a
novel technology for the manufacture and delivery of therapeutic
proteins continuously in patients using their own tissue, clarifies
the information given in its announcement of 8 June 2011 with
respect to a block admission application. The Company has made an
application for a block admission, in accordance with the AIM
Rules, for 963,119 common shares of par value U.S. $0.0001 each in
the Company ("Common Shares") under the MEDG line and 963,119
Common Shares under the MEDU line (in relation to the Company's
outstanding warrants and options under its share incentive plans),
which together represent approximately 20% of the Company's
currently issued share capital. It is now expected that this block
admission will be effective from 6 July 2011.
For further information, contact:
Medgenics, Inc. Phone: +972 4 902 8900
Dr. Andrew L. Pearlman
Religare Capital Markets (Nominated Phone: +44 20 7444 0800
Adviser)
James Pinner
Derek Crowhurst
SVS Securities plc (Joint Broker) Phone: +44 20 7638 5600
Ian Callaway
Nomura Code Securities PLC (Joint Phone: +44 20 7776 1219
Broker)
Jon Senior
De Facto Financial Phone: +44 207 556 1064
Mike Wort
Anna Dunphy
Lippert/Heilshorn & Associates, Inc. Phone: +1 212-838-3777
(Investment Relations - US)
Anne Marie Fields
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISKMGGNDMRGMZM
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jul 2023 to Jul 2024